The Association of FLT3-ITD Gene Mutation with Bone Marrow Blast Cell Count, CD34, Cyclin D1, Bcl-xL and hENT1 Expression in Acute Myeloid Leukemia Patients
Background & Objective: FLT3-ITD has been recently used as a molecular prognostic marker for risk classification in acute myeloid leukemia (AML) therapy. In this study we aimed to investigate the association of FLT3-ITD gene mutation with bone marrow blast cell count, CD34 expression as maligna...
Saved in:
Main Authors: | Paulus Notopuro (Author), Jusak Nugraha (Author), Budi Utomo (Author), Harianto Notopuro (Author) |
---|---|
Format: | Book |
Published: |
Iranian Society of Pathology,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular detection of interleukin-1A +4845 <sub>G→T</sub> gene in aggresive periodontitis patients
by: Chiquita Prahasanti, et al.
Published: (2012) -
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study
by: Lenka N. C. Boyd, et al.
Published: (2023) -
MDM2-BCL-XL PROTACs enable degradation of BCL-XL and stabilization of p53
by: Mengyang Chang, et al.
Published: (2022) -
Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1
by: Li Liu, et al.
Published: (2024) -
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy
by: Sankaranarayan Kannan, et al.
Published: (2022)